The global Zika virus testing market size is expected to reach USD 328.3 million in 2028 and register a CAGR of 7.9% according to the latest report by Reports and Data. Rising prevalence of Zika virus and growing adoption of technologically advanced tests across several countries are key factors driving global market revenue growth.

Zika virus is a member of Flaviviridae family, which is transmitted by daytime active Aedes mosquitoes, causative agents of various infections including fever, Japanese encephalitis, yellow fever, and dengue. Joint and muscle pain, rash, conjunctivitis, fever, and headache are some of the common systems of Zika virus infection. It can be transmitted from one person to another through sexual contact or from infected mother to fetus. Infected pregnant women have high risks of miscarriage, preterm birth, or serious birth defects including microcephaly or other congenital brain abnormalities. This has encouraged Zika virus testing among pregnant women. Increasing investments by market players in research and development activities to develop innovative and advanced tests and growing public awareness about Zika virus infection, transmission, and benefits of early decision are fueling global market growth.  

However, factors, such as slow implementation of advanced technologies in developing countries and high cost of branded test kits, are expected to impede growth of the Zika Virus market to a certain extent. In addition, IgM test seems to cause several side effects such as multiple punctures for locating patient’s vein, fainting, or hematoma which is another crucial factor projected to hamper global market growth. 

Market Overview:

The pharma and healthcare industry is at a crossroads. Patients are benefiting from the promise of cell and gene therapies; uncommon diseases that were previously thought to be incurable are on the verge of finding true treatments. Artificial intelligence (AI) and machine-learning technologies are creating hopes that therapy discovery and development would be more innovative, as well as faster and cheaper. Manufacturing, the supply chain, and the entire healthcare ecosystem all have the potential to benefit from data-driven initiatives. Consumer attitudes and behaviors are shifting in a variety of ways, from the growing use of technology and willingness to share data to an interest in using tools to make prescription and treatment decisions. Such factors will drive pharma and healthcare market growth in the coming years.

Key Players covered in this report are:

Abbott Laboratories, Altona Diagnostics GmbH, Chembio Diagnostic Systems Inc., ELITechGroup, F. Hoffmann-La Roche Ltd, Genekam, Luminex Corporation, Novacyt Group, Quest Diagnostics, and Siemens AG 

Test Type Outlook (Revenue, USD Million, 2018-2028)

• Molecular Testing
  • Nucleic Acid Amplification Testing (NAAT)
  • Polymerase Chain Reaction (PCR)
• Serological Testing
  • Enzyme-Linked Immune Sorbent Assay (ELISA)
  • Plaque Reduction and Neutralization Test (PRNT)

End-Use Outlook (Revenue, USD Million, 2018-2028)

• Diagnostic Laboratory
• Hospital and Clinics
• Research Institutes

Based on Region market is segmented into:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East Africa

Request a sample Report of Zika Virus Testing Market @ https://www.reportsanddata.com/request-customization-form/4040 

Major Points covered in this report are as below:

• The Zika Virus Testing industry development trends and marketing channels are analyzed. The feasibility of new investment projects is assessed and overall research conclusions are offered.

• With the tables and figures, the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

• Development policies and plans, manufacturing processes, and cost structures are also analyzed. This report also states import/export consumption, supply and demand figures, cost, price, revenue, and gross margins.

• The Zika Virus Testing Market report provides key statistics on the market status of the Zika Virus Testing manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

We can also provide customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central South America, Brazil, Argentina, Rest of South America, Middle East Africa, Saudi Arabia, Turkey, Rest of Middle East Africa

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.